We must optimize stent deployment & maintain a registry of how well (or poorly) we use drug-eluting stents. Instead of asking “Which stent?” or “How much ...We must optimize stent deployment & maintain a registry of how well (or poorly) we use drug-eluting stents. Instead of asking “Which stent?” or “How much anti-platelet therapy?” we must ask “How effectively are we deploying our stents?”
to BMS DES IIb/IIIa IVUS MI SIRIUS ST-elevation TAXUS abbott angiogram angiography angioplasty anti-platelet antiplatelet apposition artery aspirin balloons bare-metal boston_scientifics cardiologists cardiology clopidogrel compliant coronary deformation deployed deployment direct directly-stented drug-eluting drugs endothelialization endpoints guidant incomplete infarction interventional intravascular ischemia johnson_&_johnson lesions methods myocardial non-compliant occlusion occlusions platelet polymer polymerization quality receptors restenosis semi-compliant stenting stents stiffening struts techniques thienopyridine thrombogenicity thrombosis total ultrasound unapposed vasculature vessel by avivagabriel on Jul 12, 2007, 4:51 AM